Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996
Improvement of Both Tardive Dystonia and Akathisia after Botulism Toxin Injection
Neurol 46:844-845, Shulman,L.M.,et al, 1996
Botulinum Toxin Versus Trihexphenidyl in Cervical Dystonia:A Prospective, Randomized, Double-Blind Controlled Study
Neurol 46:1066-1072, Brans,J.W.M.,et al, 1996
Manganese Toxicity in Children Receiving Long-Term Parental Nutrition
Lancet 347:1218-1221, Fell,J.M.E.,et al, 1996
Dementia After First Stroke
Stroke 27:1205-1210, Censori,B.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
MRI of Cerebellopontine Angle Choroid Plexus Papilloma
Neuroradiology 38:38-40, Tasdemiroglu,E.,et al, 1996
Effectiveness Versus Efficacy of Treatment of Hypertension for Stroke Prevention
Neurol 46:301-307, Whisnant,J.P., 1996
The Relation Between Fish Consump & Stroke Incidence, NHANES I Epidemiol Study
Arch Int Med 156:537-542, Gillum,R.F.,et al, 1996
Striatopallidal and Thalamic Dystonia, A Magnetic Resonance Imaging Anatomoclinical Study
Arch Neurol 53:241-250, Lehericy,S.,et al, 1996
Neuroimaging Findings in Patients on Immunosuppressive Therapy:Experience with Tacrolimus Toxicity
AJR 166:683-688, Appignani,B.A.,et al, 1996
AIDS and Cerbrovascular Disease
Stroke 27:538-543, Pinto,A.N., 1996
Cognitive Dysfunction as the Major Presenting Feature of Becker's Muscular Dystrophy
Neurol 46:461-465, North,K.N.,et al, 1996
Clinical Heterogeneity of Adhalin Deficiency
Ann Neurol 39:196-202, Morandi,L.,et al, 1996
Diagnosis of Merosin (Laminin-2) Deficient Congenital Muscular Dystrophy by Skin Biopsy
Lancet 347:582-584, Sewry,C.A.,et al, 1996
From Enigmatic to Problematic:The New Molecular Genetics of Childhood Spinal Muscular Atrophy
Neurol 46:335-340, Crawford,T.O., 1996
Treatment of Opsoclonus-Myoclonus with High-Dose Intravenous Immunoglobulin
Neurol 46:583-584, Pless,M.,et al, 1996
Chemotherapy without Radiation Therapy as Initial Treatment for Primary CNS Lymphoma in Older Patients
Neurol 46:435-439, Freilich,R.J.,et al, 1996
Nonenhancing Primary Central Nervous System Lymphoma
NEuroradiology 38:34-37, Terae,S.&Ogata,A., 1996
Gliomatosis Cerebri
Radiology 198:831-835, delCarpio-O'Donovan,R.,et al, 1996
MRI of White Matter Changes in the Sjogren-Larsson Syndrome
Neuroradiology 37:576-577, Hussain,M.Z.&Aihara,M., 1996
A 64-Year-Old Man with Diabetes and Ascending Paraplegia
Lancet 347:516, Gliemroth,J.,et al, 1996
Postictal Psychiatric Events During Prolonged Video-Electroencephalographic Monitoring Studies
Arch Neurol 53:258-263, Kanner,A.M.,et al, 1996
Clinicopath Conf
Focal Cortical Dysplasia, Case 7-1996, NEJM 334:586-592996., , 1996
Cognitive Impairment & Mortality in a Cohort of Elderly People
BMJ 312:608-611, Gale,C.R.,et al, 1996
Meningeal Gliomatosis Presenting as Multiple Cerebral Infarcts:A Case Report
Neurol 46:1760-1762, Moonis,M.&Smith,T.W., 1996
Evolution of High-Intensity Basal Ganglia Lesions on T1-Weighted MR in Neurofibramotisis Type 1
AJNR 17:755-760, Terada,H.A.,et al, 1996
The Stroke Syndrome of Cortical Vein Thrombosis
Neurol 47:376-382, Jacobs,K.,et al, 1996
The Evolution of Surgery for the Treatment and Prevention of Stroke
Stroke 27:1427-1434, Thompson,J.E., 1996
Aspirin in Ischemic Cerebrovascular Disease-How Strong is the Case for a Different Dosing Regimen
Stroke 27:756-760, Patrono,C.&Roth,G.J., 1996
Aspirin Wars-The Optimal Dose of Aspirin to Prevent Stroke
Stroke 27:585-587, Hart,R.G.&Harrison,M.J.G., 1996
Aspirin Dose in Stroke Prevention-Beautiful Hypotheses Slain by Ugly Facts
Stroke 27:588-592, Barnett,H.J.M.,et al, 1996
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
Lipids and Stroke
Arch Neurol 53:303-308, Hachinski,V.,et al, 1996
Intravenous Immunoglobin Treatment in Paraneoplastic Neurological Syndromes with Antineuronal Autoantibodies
JNNP 60:388-392, Uchuya,M.,et al, 1996
Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration in a Man with Adenocardinoma of Unknown Origin
Neurol 46:1486-1487, Krakauer,J.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Human T-Cell Lymphotropic Virus Type 1-Associated Myelopathy, Sjogren Syndrome, and Lymphocytic Pneumonitis
Arch Neurol 53:940-942, Kompoliti,A.,et al, 1996
The Management of Brainstem Gliomas in Patients with Neurofibromatosis 1
Neurol 46:1652-1660, Pollack,I.F.,et al, 1996
An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996
Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996
BSE Linked to New Variant of CJD in Humans
BMJ 312:795, 791, 843, 85496., , 1996
A New Variant of Creutzfeldt-Jakob Disease in the UK
Lancet 347:921-925, 915, 916, 91796., Will,R.G.,et al, 1996
Creutzfeldt-Jakob Disease in a Young Woman
Lancet 347:945-948, Tabrizi,S.J.,et al, 1996
Progressive Multifocal Leukoencephalopathy:Clinical and MR Response to Treatment
AJNR 17:597-600, Garrels,K.,et al, 1996
Subacute Leukoencephalitis Caused by CNS Infection with Human Herpesvirus-6 Manifesting as Acute Multiple Sclerosis
Neurol 47:145-148, Carrigan,D.R.,et al, 1996
Prenatal Diagnosis of Duchenne Muscular Dystrophy Using a Single Fetal Nucleated Erythrocyte in Maternal Blood
Neurol 46:1350-1353, Sekizawa,A.,et al, 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies
JAMA 275:1335-1338, Politano,L.,et al, 1996
Inclusion Body Myositis
JNNP 60:251-255, Garlepp,M.J.&Mastaglia,F.L., 1996